MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
- Resource Type
- Article
- Authors
- Løkkegaard, Sanne; Elias, Daniel; Alves, Carla L.; Bennetzen, Martin V.; Lænkholm, Anne-Vibeke; Bak, Martin; Gjerstorff, Morten F.; Johansen, Lene E.; Vever, Henriette; Bjerre, Christina; Kirkegaard, Tove; Nordenskjöld, Bo; Fornander, Tommy; Stål, Olle; Lindström, Linda S.; Esserman, Laura J.; Lykkesfeldt, Anne E.; Andersen, Jens S.; Leth-Larsen, Rikke; Ditzel, Henrik J.
- Source
- NPJ Breast Cancer; 1/4/2021, Vol. 7 Issue 1, p1-15, 15p
- Subject
- Language
- ISSN
- 23744677